Chairperson(s) : Jae Hyoung Park (Korea University, Republic of Korea)
Chairperson(s) : Sang-Hak Lee (Yonsei University, Republic of Korea), Sungha Park (Yonsei University, Republic of Korea)
Panel(s) : Gyu Chul Oh (The Catholic University of Korea, Republic of Korea), Ji-Yong Jang (National Health Insurance Service Ilsan Hospital, Republic of Korea), Yun Kyung Cho (University of Ulsan, Republic of Korea)
-
Bempedoic acid: LDL-C lowering beyond statins - evidence and clinical role
Chewan Lim Catholic Kwandong University, Republic of Korea 08:30~08:50 -
Optimizing non-statin therapy: PCSK9 inhibitors and inclisiran
Kyung-Hee Kim Incheon Sejong Hospital, Republic of Korea 08:50~09:10 -
Emerging Lp(a)-lowering therapies: siRNA, ASO, and beyond
Yu-Chen Wang Asia University, Taiwan 09:10~09:30 - Panel Discussion 09:30~10:00
Chairperson(s) : Kyong Soo Park (Konkuk University, Republic of Korea), Myung A Kim (Jeju National University, Republic of Korea)
Chairperson(s) : Mi-Seung Shin (Gachon University, Republic of Korea), Jun-Hee Lee (Hallym University, Republic of Korea)
Panel(s) : Hack-Lyoung Kim (Seoul National University, Republic of Korea), Ye Seul Yang (Seoul National University, Republic of Korea), Seok Oh (Chonnam National University, Republic of Korea)
-
Sex differences in lipids and lipoproteins and residual cardiovascular risk: beyond LDL cholesterol
Soo-Jin Kim Kosin University, Republic of Korea 12:45~13:00 -
Early-onset dyslipidemia in young adults: screening strategies and lifetime ASCVD risk assessment
Jaehyun Bae Hallym University, Republic of Korea 13:00~13:15 -
Menopause and cardiometabolic transition: optimizing lipid management in midlife women
In-Jeong Cho Ewha Womans University, Republic of Korea 13:15~13:30 - Panel Discussion 13:30~13:45
Chairperson(s) : Donghoon Choi (Yonsei University, Republic of Korea), Kyung Woo Park (Seoul National University, Republic of Korea)
Panel(s) : Jaehyun Bae (Hallym University, Republic of Korea), Heung Yong Jin (Jeonbuk National University, Republic of Korea), Jung-Kyu Han (Seoul National University, Republic of Korea)
-
Lipoprotein(a) in Korean patients: real-world data, cardiovascular risk, and clinical implications
Sang Min Park Eulji University, Republic of Korea 13:45~14:05 -
Lipoprotein(a) and coronary atherosclerosis in Vietnam: real-world data and emerging cardiovascular risk
Anh Tien Hoang Hue University, Vietnam 14:05~14:25 -
Measuring Lipoprotein(a) in clinical practice: assay challenges, standardization, and interpretation
Sang-Guk Lee Yonsei University, Republic of Korea 14:25~14:45 - Panel Discussion 14:45~15:15
Chairperson(s) : Sang Yup Lim (Korea University, Republic of Korea), Soon Jun Hong (Korea University, Republic of Korea)
Panel(s) : Byung Sik Kim (Hanyang University, Republic of Korea), Eun-Jung Rhee (Sungkyunkwan University, Republic of Korea), Jang Hoon Lee (Kyungpook National University, Republic of Korea)
-
CETP inhibition revisited: obicetrapib for LDL-C reduction and ASCVD risk management
Mariko Harada-Shiba Osaka Medical and Pharmaceutical University, Japan 16:10~16:30 -
APOC3 inhibition: targeting triglyceride-rich lipoproteins and residual risk
Jin Wi Gachon University, Republic of Korea 16:30~16:50 -
ANGPTL3 inhibition: expanding therapeutic opportunities beyond LDL-C
Hye Moon Chung Kyung Hee University, Republic of Korea 16:50~17:10 - Panel Discussion 17:10~17:40
